Kalyra Pharmaceuticals, Inc. — Form D/A
Kalyra Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2013-11-08. The offering totals $7.0M, of which $6.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-11-08
- Form: D/A
- Accession: 0001140361-13-041286
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $6.2M
- Remaining: $819K
- Investors: 32
- Date of first sale: 2013-08-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-201695
Issuer
- Name: Kalyra Pharmaceuticals, Inc.
- CIK: 0001584696
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2012
- Address: 6181 CORNERSTONE COURT, SAN DIEGO, CA, 92121
- Phone: (858) 901-1942
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Michael E Breede | Director | San Deigo, CA |
| Kevin D Bunker | Director | San Diego, CA |
| Cam L Garner | Director | San Diego, CA |
| Scott L Glenn | Director | Boulder, CO |
| Ned A Israelsen | Director | San Diego, CA |
| Dirk A Thye | Director | San Diego, CA |
| Kevin D Bunker | Executive Officer | San Diego, CA |
| Cam L Gallagher | Executive Officer | San Diego, CA |
| Ned A Israelsen | Executive Officer | San Diego, CA |
Other filings by this issuer (1)
More